Literature DB >> 24061980

[Nationwide speaking tour of standardized diagnosis and treatment for esophageal cancer].

You-sheng Mao1, Jie He, Qi Xue, Kang Shao, Kai Su, Ning Li, Feng-wei Tan, Jia Zhou.   

Abstract

For a long time, the diagnosis and treatment protocol for esophageal cancer has been made either entirely based on the experience of Western countries or on our own experience alone. A suitable standardized guideline for diagnosis and treatment of esophageal cancer in our country has not been established until 2010. Due to lack of opportunities for mutual exchange and learning, the overall level of standardized diagnosis and treatment was relatively low in China. In addition, less advanced technologies were applied and varying treatment protocols were implemented in different districts, the treatment results has been unsatisfactory, and the overall 5-year survival rate after surgical treatment has been maintained from 30% to 40%. Therefore, it is imperative that China needs to conduct its own clinical studies and establish its own suitable standardized treatment and diagnosis guideline for esophageal cancer. This article reviews and also made comments on the process of academic speaking tour and development of standardized diagnosis and treatment guidelines as well as the problems resolved by these activities for esophageal cancer since the beginning of this century.

Entities:  

Mesh:

Year:  2013        PMID: 24061980

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  6 in total

1.  Comparison of Ivor Lewis and Sweet esophagectomy for middle and lower esophageal squamous cell carcinoma: A systematic review and pooled analysis.

Authors:  Yuhang Xue; Donglai Chen; Wei Wang; Wenjia Wang; Lei Chen; Yonghua Sang; Yongbing Chen; Weihua Xu
Journal:  EClinicalMedicine       Date:  2020-10-10

2.  Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.

Authors:  Qi Wang; Zixiang Wu; Tianwei Zhan; Shuai Fang; Sai Zhang; Gang Shen; Ming Wu
Journal:  BMC Cancer       Date:  2019-05-27       Impact factor: 4.638

3.  Right versus left thoracic approach oesophagectomy for oesophageal cancer: a systematic review and meta-analysis protocol.

Authors:  Tianci Chai; Zhimin Shen; Sui Chen; Yuhan Lin; Zhenyang Zhang; Wenwei Lin; Junjie Hong; Chuangcai Yang; Mingqiang Kang; Jiangbo Lin
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

4.  Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma.

Authors:  Yan Zheng; Yin Li; Xianben Liu; Haibo Sun; Guanghui Liang; Jiajia Hu; Liping Li; Wenqun Xing
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

5.  Building CT Radiomics Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction.

Authors:  Chen Shen; Zhenyu Liu; Zhaoqi Wang; Jia Guo; Hongkai Zhang; Yingshu Wang; Jianjun Qin; Hailiang Li; Mengjie Fang; Zhenchao Tang; Yin Li; Jinrong Qu; Jie Tian
Journal:  Transl Oncol       Date:  2018-05-01       Impact factor: 4.243

6.  Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma.

Authors:  Yan Zheng; Yin Li; Xianben Liu; Ruixiang Zhang; Haibo Sun; Wenqun Xing
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.